"Tisch Cancer Institute Appoints Director Of Center For Carcinoid And Neuroendocrine Tumors"
Edward M. Wolin, MD, has been appointed director of the Center for Carcinoid and Neuroendocrine Tumors at Mount Sinai Health System's Tisch Cancer Institute. Dr. Wolin also will serve as professor of medicine at Icahn School of Medicine at Mount Sinai. "We are very excited about Dr. Wolin joining The Tisch Cancer Institute. With his remarkable expertise and research experience, Dr. Wolin will lead Mount Sinai's program to a new level of prominence," William K. Oh, MD, chief of hematology and medical oncology for Mount Sinai Health System, and associate director for clinical and translational research and deputy director of Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai, said in a press release. "We look forward to advancing our program, which is one of the only neuroendocrine tumor centers in the country, and providing optimal care for patients from around the world."
- William K. Oh, MD, Professor, Medicine, Hematology, Medical Oncology, Urology, Chief, Division of Hematology and Medical Oncology, Associate Director, Clinical Research, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
- Edward M. Wolin, MD, Director, Center for Carcinoid and Neuroendocrine Tumors, Tisch Cancer Institute, Professor, Medicine, Hematology, Medical Oncology, Icahn School of Medicine at Mount Sinai